Company Filing History:
2 out of 3 
1 out of 987 
1 out of 49 
Years Active: 2012-2015
Title: Hideo Kobayashi: Innovator in Cardiac Therapeutics and Nucleic Acid Transfection
Introduction
Hideo Kobayashi is a notable inventor based in Edogawa-ku, Japan. He has made significant contributions to the fields of cardiac therapeutics and nucleic acid transfection. With a total of 3 patents, his work has the potential to impact medical treatments and biotechnology.
Latest Patents
Kobayashi's latest patents include a novel prophylactic and/or therapeutic agent for cardiac infarction. This invention relates to a drug designed to prevent or treat myocardial infarction, utilizing a lipid membrane structure that retains adenosine. Another significant patent is a composition for nucleic acid transfection, which exhibits low cytotoxicity and facilitates effective nucleic acid transfection into cells. This composition includes a di(Calkyl)dimethylammonium halide and a phospholipid, improving the expression of nucleic acids within cells.
Career Highlights
Throughout his career, Hideo Kobayashi has worked with various organizations, including Hokkaido System Science Co., Ltd. and Osaka University. His experience in these institutions has contributed to his innovative research and development in the medical and biotechnology sectors.
Collaborations
Kobayashi has collaborated with notable colleagues such as Hiroshi Kikuchi and Kouichi Hashimoto. These partnerships have likely enhanced his research capabilities and broadened the impact of his inventions.
Conclusion
Hideo Kobayashi's contributions to cardiac therapeutics and nucleic acid transfection demonstrate his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to improving health outcomes through research and development.